AFP and hepatocellular carcinoma: Some glycoproteins with aberrant glycosylation have been used as biomarkers for HCC diagnosis, such as AFP-L3 [8], aleuria aurantia lectin (AAL)-reactive α1-antitrypsin [9], α-1,3 fucosylated multiantennary glycan on hemopexin [10].